November 10, 2022
November 10, 2022 —
An international symposium November 17-18, 2022 at UC San Diego will discuss current clinical trials using gene therapy, here and abroad.
November 10, 2022
November 10, 2022 —
Eight researchers from UC San Diego are listed in the first-ever ranking of the “1,000 Best Female Scientists in the World” by research.com, an analytics platform that advocates for improved research quality and also ranks universities, scholarly journals and academic conferences.
November 7, 2022
November 7, 2022 —
UC San Diego Health has earned The Joint Commission’s Gold Seal of Approval for Advanced Certification in Spine Surgery by meeting or exceeding the highest level of national performance standards.
November 3, 2022
November 3, 2022 —
Using human brain organoids, an international team of researchers has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses — the connections between brain cells that allow them to communicate with each other.
November 3, 2022
November 3, 2022 —
This season there are three prevalent respiratory viruses to be aware of—influenza, SARS-CoV-2 and respiratory syncytial virus (RSV), all of which are transmitted via aerosols.
November 1, 2022
November 1, 2022 —
New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.
November 1, 2022
November 1, 2022 —
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe the first preclinical model of appendiceal cancer that contains all elements of the tumor, allowing previously stymied investigations to proceed.
November 1, 2022
November 1, 2022 —
The U.S. National Science Foundation announced $30 million in research awards to support new interdisciplinary, fundamental research projects for the Emerging Frontiers in Research and Innovation (EFRI) program — 20 percent of the funding was awarded to UC San Diego researchers.
October 31, 2022
October 31, 2022 —
Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.
October 31, 2022
October 31, 2022 —
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.